Seastar Medical Hldg Corp (ICU)

$3.03 -0.10 (-3.19%)
Market Cap 13.35M
Revenue (ttm) 1.23M
Net Income (ttm) -12.15M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -987.80%
Debt to Equity Ratio 0.00
Volume 44,900
Avg Vol 72,170
Day's Range N/A - N/A
Shares Out 4.41M
Stochastic %K 38%
Beta -1.05
Analysts Strong Sell
Price Target $10.00

Company Profile

SeaStar Medical Holding Corporation, a commercial-stage healthcare company, develops a proprietary platform therapy to reduce the consequences of hyperinflammation on vital organs in the United States. The company offers the selective cytopheretic device (SCD), which is a disease-modifying device that neutralizes over-active immune cells and stops the cytokine storm that yields destructive hyperinflammation; and QUELIMMUNE, an SCD therapy for pediatric patients with acute kidney injury (AKI) due...

Industry: Biotechnology
Sector: Healthcare
Phone: 844 427 8100
Address:
3513 Brighton Boulevard, Suite 410, Denver, United States
frogtrainer
frogtrainer Sep. 13 at 3:48 AM
$ICU is something supposed to happen on Monday?
0 · Reply
Duoma
Duoma Sep. 12 at 9:17 PM
$ICU Monday big bomb
1 · Reply
ICUBullbear
ICUBullbear Sep. 12 at 1:08 PM
$ICU if these prices are a gift youd think the insiders would be loading up..just looks like are mostly taking dilution shares 🚩🚩🚩
0 · Reply
et1000
et1000 Sep. 11 at 11:00 PM
Ticker MLEC is the next nano float runner ! Every small float ticker has been running almost 500% recently Would not be surprised if they send MLEC up next. MLEC starting to make its move now! Only 573k shares outstanding! 💎 $QQQ $ALT $ICU $NVAX in
1 · Reply
techjerk
techjerk Sep. 11 at 10:38 PM
$ICU SeaStar Medical did not exist during the September 11, 2001 terrorist attacks. 2007 (Founding): SeaStar Medical Holding Corporation was officially founded, coming into existence roughly six years after the 9/11 attacks occurred. 2022 (Public Listing): The company went public via a SPAC merger and began trading on the Nasdaq under the ticker symbol ICU.
1 · Reply
techjerk
techjerk Sep. 11 at 10:04 PM
$ICU investers here like vampires .. suck those shares!? i
1 · Reply
techjerk
techjerk Sep. 11 at 9:36 PM
$ICU .. 5050 from the past has riled thee .. ha
0 · Reply
local42r
local42r Sep. 11 at 9:13 PM
$ICU looks like you answered your own question.
1 · Reply
BULLISH1975
BULLISH1975 Sep. 11 at 7:03 PM
$ICU i like when Eric says SCD is working in the real world- results in line with trials. We know SAVE data is good. We know FDA dropped SAVE requirement from 300 - 50!!!!!! We have many shots at goal. Ped market is 100 million top 50 hospitals apparently treat half patients- about 50 million revenue We already have about 40 % of the top hospitals- this should mean about 20 million revenue potential from current hospital clients!!!!!! tock tock small fry compared to Adult BUt we making progress- just SP needs to catch UP👍
0 · Reply
BULLISH1975
BULLISH1975 Sep. 11 at 6:57 PM
$ICU investers dont flip every day or week. volume today is traders selling in a friday and some were hoping ICU was getting new data today. i holdddd stronggggg
2 · Reply
Latest News on ICU
SeaStar Medical Holding Transcript: H.C. Wainwright 28th Annual Global Investment Conference

Sep 11, 2026, 7:00 AM EDT - 1 day ago

SeaStar Medical Holding Transcript: H.C. Wainwright 28th Annual Global Investment Conference

SeaStar Medical to Present at the HC Wainwright 28th Annual Global Investment Conference

Sep 10, 2026, 8:35 AM EDT - 2 days ago

SeaStar Medical to Present at the HC Wainwright 28th Annual Global Investment Conference

SeaStar Medical Holding Earnings Call Transcript: Q2 2026

Aug 12, 2026, 4:30 PM EDT - 4 weeks ago

SeaStar Medical Holding Earnings Call Transcript: Q2 2026

SeaStar Medical Holding Earnings release: Q2 2026

Aug 12, 2026, 4:30 PM EDT - 4 weeks ago

SeaStar Medical Holding Earnings release: Q2 2026

SeaStar Medical Holding Quarterly report: Q2 2026

Aug 12, 2026, 4:30 PM EDT - 4 weeks ago

SeaStar Medical Holding Quarterly report: Q2 2026

SeaStar Medical Reports Second Quarter 2026 Financial Results and Provides Business Updates

Aug 12, 2026, 4:05 PM EDT - 4 weeks ago

SeaStar Medical Reports Second Quarter 2026 Financial Results and Provides Business Updates

SeaStar Medical Holding Slides: Investor presentation

Aug 12, 2026, 7:00 AM EDT - 4 weeks ago

SeaStar Medical Holding Slides: Investor presentation

SeaStar Medical to Report Second Quarter Financial Results on August 12, 2026

Aug 6, 2026, 8:35 AM EDT - 5 weeks ago

SeaStar Medical to Report Second Quarter Financial Results on August 12, 2026

SeaStar Medical Supports Advances in Critical Care of Pediatric Patients with Acute Kidney Injury (AKI)

Jul 14, 2026, 8:34 AM EDT - 2 months ago

SeaStar Medical Supports Advances in Critical Care of Pediatric Patients with Acute Kidney Injury (AKI)

SeaStar Medical Holding Transcript: Investor Summit Virtual Conference

Jun 24, 2026, 10:30 AM EDT - 2 months ago

SeaStar Medical Holding Transcript: Investor Summit Virtual Conference

SeaStar Medical announces new CD-10-PCS codes for SCD therapy

2026-06-23T16:34:58.000Z - 2 months ago

SeaStar Medical announces new CD-10-PCS codes for SCD therapy

SeaStar Medical Announces New ICD-10-PCS Codes for Its SCD Therapy for Acute Kidney Injury

Jun 23, 2026, 8:25 AM EDT - 2 months ago

SeaStar Medical Announces New ICD-10-PCS Codes for Its SCD Therapy for Acute Kidney Injury

SeaStar Medical to Present at Upcoming Investor Summit Conference

Jun 22, 2026, 8:45 AM EDT - 2 months ago

SeaStar Medical to Present at Upcoming Investor Summit Conference

SeaStar Medical price target raised to $8 from $6 at Maxim

2026-05-14T14:34:45.000Z - 4 months ago

SeaStar Medical price target raised to $8 from $6 at Maxim

SeaStar Medical Holding Earnings Call Transcript: Q1 2026

May 13, 2026, 4:30 PM EDT - 4 months ago

SeaStar Medical Holding Earnings Call Transcript: Q1 2026

SeaStar Medical Holding Earnings release: Q1 2026

May 13, 2026, 4:30 PM EDT - 4 months ago

SeaStar Medical Holding Earnings release: Q1 2026

SeaStar Medical Holding Quarterly report: Q1 2026

May 13, 2026, 4:30 PM EDT - 4 months ago

SeaStar Medical Holding Quarterly report: Q1 2026

SeaStar Medical Reports First Quarter Financial Results and Provides Business Updates

May 13, 2026, 4:05 PM EDT - 4 months ago

SeaStar Medical Reports First Quarter Financial Results and Provides Business Updates

SeaStar Medical Holding Registration statement: Registration filing

May 7, 2026, 8:00 AM EDT - 4 months ago

SeaStar Medical Holding Registration statement: Registration filing

SeaStar Medical to Report First Quarter Financial Results on May 13, 2026

May 6, 2026, 8:20 AM EDT - 4 months ago

SeaStar Medical to Report First Quarter Financial Results on May 13, 2026

SeaStar Medical Holding Proxy statement: Proxy filing

Apr 29, 2026, 8:00 AM EDT - 4 months ago

SeaStar Medical Holding Proxy statement: Proxy filing

SeaStar Medical Holding Registration statement: Registration filing

Apr 28, 2026, 8:00 AM EDT - 4 months ago

SeaStar Medical Holding Registration statement: Registration filing

SeaStar Medical showcases new data from SAVE Registry

2026-03-30T13:27:26.000Z - 5 months ago

SeaStar Medical showcases new data from SAVE Registry

SeaStar Medical Showcases New Positive Data from the QUELIMMUNE SAVE Registry and an Analysis of the Unique Immunomodulatory Mechanism of the SCD Therapy at AKI & CRRT 2026

Mar 30, 2026, 8:20 AM EDT - 5 months ago

SeaStar Medical Showcases New Positive Data from the QUELIMMUNE SAVE Registry and an Analysis of the Unique Immunomodulatory Mechanism of the SCD Therapy at AKI & CRRT 2026

SeaStar Medical Holding Earnings Call Transcript: Q4 2025

Mar 25, 2026, 4:30 PM EDT - 5 months ago

SeaStar Medical Holding Earnings Call Transcript: Q4 2025

SeaStar Medical Holding Annual report: Q4 2025

Mar 25, 2026, 4:30 PM EDT - 5 months ago

SeaStar Medical Holding Annual report: Q4 2025

SeaStar Medical Holding Earnings release: Q4 2025

Mar 25, 2026, 4:30 PM EDT - 5 months ago

SeaStar Medical Holding Earnings release: Q4 2025

SeaStar Medical Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Updates

Mar 25, 2026, 4:05 PM EDT - 5 months ago

SeaStar Medical Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Updates

SeaStar Medical to Report Fourth Quarter and Year-End 2025 Financial Results on March 25, 2026

Mar 18, 2026, 4:05 PM EDT - 5 months ago

SeaStar Medical to Report Fourth Quarter and Year-End 2025 Financial Results on March 25, 2026

SeaStar Medical Holding Transcript: Life Sciences Virtual Investor Forum

Mar 11, 2026, 12:00 PM EDT - 6 months ago

SeaStar Medical Holding Transcript: Life Sciences Virtual Investor Forum

SeaStar Medical to Present at the Life Sciences Investor Forum on March 11th

Mar 9, 2026, 8:35 AM EDT - 6 months ago

SeaStar Medical to Present at the Life Sciences Investor Forum on March 11th

SeaStar Medical completes FDA enrollment requirement for SAVE Registry

2026-03-05T13:36:45.000Z - 6 months ago

SeaStar Medical completes FDA enrollment requirement for SAVE Registry

SeaStar Medical Announces Completion of FDA Enrollment Requirement for SAVE Surveillance Registry Evaluating QUELIMMUNE Safety for Pediatric AKI

Mar 5, 2026, 8:20 AM EST - 6 months ago

SeaStar Medical Announces Completion of FDA Enrollment Requirement for SAVE Surveillance Registry Evaluating QUELIMMUNE Safety for Pediatric AKI

SeaStar Medical price target lowered to $6 from $10 at Maxim

2026-02-12T14:06:17.000Z - 7 months ago

SeaStar Medical price target lowered to $6 from $10 at Maxim

SeaStar Medical reports ‘strong’ survival data in Quelimmune study

2026-02-09T13:25:53.000Z - 7 months ago

SeaStar Medical reports ‘strong’ survival data in Quelimmune study

SeaStar Medical Announces Publication in Pediatric Nephrology of Positive Real-World Experience for QUELIMMUNE™ (SCD-PED) Therapy in Pediatric Acute Kidney Injury (AKI)

Feb 9, 2026, 8:20 AM EST - 7 months ago

SeaStar Medical Announces Publication in Pediatric Nephrology of Positive Real-World Experience for QUELIMMUNE™ (SCD-PED) Therapy in Pediatric Acute Kidney Injury (AKI)

SeaStar Medical to Present at Upcoming Noble Capital Markets Emerging Growth Virtual Equity Conference

Jan 29, 2026, 8:25 AM EST - 7 months ago

SeaStar Medical to Present at Upcoming Noble Capital Markets Emerging Growth Virtual Equity Conference

SeaStar Medical Holding Transcript: Biotech Showcase 2026

Jan 13, 2026, 6:00 PM EST - 8 months ago

SeaStar Medical Holding Transcript: Biotech Showcase 2026

SeaStar Medical Holding Slides: Investor presentation

Jan 9, 2026, 7:00 AM EST - 8 months ago

SeaStar Medical Holding Slides: Investor presentation

SeaStar Medical announces 2026 milestones

2026-01-07T13:21:08.000Z - 8 months ago

SeaStar Medical announces 2026 milestones

SeaStar Medical Announces 2026 Milestones

Jan 7, 2026, 8:13 AM EST - 8 months ago

SeaStar Medical Announces 2026 Milestones

SeaStar Medical to Present at Upcoming Biotech Showcase 2026 Investor Conference

Jan 6, 2026, 8:53 AM EST - 8 months ago

SeaStar Medical to Present at Upcoming Biotech Showcase 2026 Investor Conference

SeaStar Medical Holding Corp trading halted, news pending

2026-01-03T00:50:17.000Z - 8 months ago

SeaStar Medical Holding Corp trading halted, news pending

SeaStar Medical announces 1-for-10 reverse stock split

2025-12-23T21:30:17.000Z - 8 months ago

SeaStar Medical announces 1-for-10 reverse stock split

SeaStar Medical Announces 1-for-10 Reverse Split

Dec 23, 2025, 4:25 PM EST - 8 months ago

SeaStar Medical Announces 1-for-10 Reverse Split

SeaStar reports approval for reduction in mandatory enrollment for SAVE registry

2025-12-02T13:30:31.000Z - 9 months ago

SeaStar reports approval for reduction in mandatory enrollment for SAVE registry

SeaStar Medical Announces FDA Approval of Reduction in Mandatory Enrollment for SAVE Surveillance Registry Evaluating QUELIMMUNE™ Safety for Pediatric AKI

Dec 2, 2025, 8:27 AM EST - 9 months ago

SeaStar Medical Announces FDA Approval of Reduction in Mandatory Enrollment for SAVE Surveillance Registry Evaluating QUELIMMUNE™ Safety for Pediatric AKI

SeaStar Medical to Present at Upcoming NobleCon21 Investor Conference

Nov 20, 2025, 9:52 AM EST - 9 months ago

SeaStar Medical to Present at Upcoming NobleCon21 Investor Conference

SeaStar Medical appoints Michael Messinger as CFO

2025-11-17T13:50:19.000Z - 9 months ago

SeaStar Medical appoints Michael Messinger as CFO

SeaStar Medical Announces Appointment of Michael Messinger as CFO

Nov 17, 2025, 8:43 AM EST - 9 months ago

SeaStar Medical Announces Appointment of Michael Messinger as CFO

SeaStar Medical Holding Proxy statement: Proxy Filing

Nov 14, 2025, 7:00 AM EST - 10 months ago

SeaStar Medical Holding Proxy statement: Proxy Filing

SeaStar Medical Holding Earnings Call Transcript: Q3 2025

Nov 13, 2025, 4:30 PM EST - 10 months ago

SeaStar Medical Holding Earnings Call Transcript: Q3 2025

SeaStar Medical Holding Quarterly report: Q3 2025

Nov 13, 2025, 4:30 PM EST - 10 months ago

SeaStar Medical Holding Quarterly report: Q3 2025

SeaStar Medical Holding Earnings release: Q3 2025

Nov 13, 2025, 4:30 PM EST - 10 months ago

SeaStar Medical Holding Earnings release: Q3 2025

SeaStar Medical Reports Third Quarter 2025 Financial Results and Provides Business Updates

Nov 13, 2025, 4:05 PM EST - 10 months ago

SeaStar Medical Reports Third Quarter 2025 Financial Results and Provides Business Updates

SeaStar Medical to Report Third Quarter Financial Results on November 13, 2025

Nov 5, 2025, 10:03 AM EST - 10 months ago

SeaStar Medical to Report Third Quarter Financial Results on November 13, 2025

SeaStar Medical Holding Proxy statement: Proxy Filing

Nov 4, 2025, 7:00 AM EST - 10 months ago

SeaStar Medical Holding Proxy statement: Proxy Filing

SeaStar Medical announces preliminary results from SAVE Surveillance Registry

2025-09-29T13:00:23.000Z - 11 months ago

SeaStar Medical announces preliminary results from SAVE Surveillance Registry

SeaStar Medical Reports Positive Early Results for QUELIMMUNE Therapy in Pediatric Acute Kidney Injury (AKI) at the 5th International Symposium on Acute Kidney Injury in Children

Sep 29, 2025, 8:36 AM EDT - 11 months ago

SeaStar Medical Reports Positive Early Results for QUELIMMUNE Therapy in Pediatric Acute Kidney Injury (AKI) at the 5th International Symposium on Acute Kidney Injury in Children

Why Is SeaStar Medical Stock (ICU) Down 45% Today?

2025-09-25T13:24:14.000Z - 11 months ago

Why Is SeaStar Medical Stock (ICU) Down 45% Today?

Review board recommends SeaStar Medical continue with NEUTRALIZE-AKI trial

2025-09-24T20:40:35.000Z - 11 months ago

Review board recommends SeaStar Medical continue with NEUTRALIZE-AKI trial

SeaStar Medical Reports DSMB Recommendation to Continue the NEUTRALIZE-AKI Pivotal Trial in Adult Acute Kidney Injury

Sep 24, 2025, 4:22 PM EDT - 11 months ago

SeaStar Medical Reports DSMB Recommendation to Continue the NEUTRALIZE-AKI Pivotal Trial in Adult Acute Kidney Injury

SeaStar Medical to Present Early SAVE Registry Data of QUELIMMUNE in Pediatric Acute Kidney Injury at the 5th International Symposium on Acute Kidney Injury in Children

Sep 23, 2025, 8:23 AM EDT - 11 months ago

SeaStar Medical to Present Early SAVE Registry Data of QUELIMMUNE in Pediatric Acute Kidney Injury at the 5th International Symposium on Acute Kidney Injury in Children

SeaStar Medical Holding Transcript: H.C. Wainwright 27th Annual Global Investment Conference

Sep 5, 2025, 7:00 AM EDT - 1 year ago

SeaStar Medical Holding Transcript: H.C. Wainwright 27th Annual Global Investment Conference

SeaStar Medical to Participate in the HC Wainwright 27th Annual Global Investment Conference

Sep 4, 2025, 6:13 PM EDT - 1 year ago

SeaStar Medical to Participate in the HC Wainwright 27th Annual Global Investment Conference

SeaStar Medical announces newly published QUELIMMUNE therapy

2025-09-02T12:45:53.000Z - 1 year ago

SeaStar Medical announces newly published QUELIMMUNE therapy

SeaStar Medical Announces Newly Published QUELIMMUNE Health Economic Study Projecting Significantly Reduced Health Care Costs in the Treatment of Pediatric AKI due to Estimated Shorter Hospital Stays and Increased Survival

Sep 2, 2025, 8:22 AM EDT - 1 year ago

SeaStar Medical Announces Newly Published QUELIMMUNE Health Economic Study Projecting Significantly Reduced Health Care Costs in the Treatment of Pediatric AKI due to Estimated Shorter Hospital Stays and Increased Survival

SeaStar Medical Holding Earnings Call Transcript: Q2 2025

Aug 13, 2025, 4:30 PM EDT - 1 year ago

SeaStar Medical Holding Earnings Call Transcript: Q2 2025

SeaStar Medical Holding Quarterly report: Q2 2025

Aug 13, 2025, 4:30 PM EDT - 1 year ago

SeaStar Medical Holding Quarterly report: Q2 2025

SeaStar Medical Holding Earnings release: Q2 2025

Aug 13, 2025, 4:30 PM EDT - 1 year ago

SeaStar Medical Holding Earnings release: Q2 2025

SeaStar Medical Reports Second Quarter 2025 Financial Results and Provides Business Updates

Aug 13, 2025, 4:05 PM EDT - 1 year ago

SeaStar Medical Reports Second Quarter 2025 Financial Results and Provides Business Updates

SeaStar Medical files to sell 10.92M shares of common stock for holders

2025-08-08T21:10:33.000Z - 1 year ago

SeaStar Medical files to sell 10.92M shares of common stock for holders

SeaStar Medical Holding Registration statement: Registration Filing

Aug 8, 2025, 8:00 AM EDT - 1 year ago

SeaStar Medical Holding Registration statement: Registration Filing

SeaStar Medical to Report Second Quarter Financial Results on August 13, 2025

Aug 7, 2025, 10:00 AM EDT - 1 year ago

SeaStar Medical to Report Second Quarter Financial Results on August 13, 2025

SeaStar Medical reaches new enrollment milestone in NEUTRALIZE-AKI trial

2025-08-06T12:42:53.000Z - 1 year ago

SeaStar Medical reaches new enrollment milestone in NEUTRALIZE-AKI trial

SeaStar Medical Reaches New Enrollment Milestone in NEUTRALIZE-AKI Pivotal Trial of SCD Therapy for Adult Patients with Acute Kidney Injury (AKI)

Aug 6, 2025, 8:33 AM EDT - 1 year ago

SeaStar Medical Reaches New Enrollment Milestone in NEUTRALIZE-AKI Pivotal Trial of SCD Therapy for Adult Patients with Acute Kidney Injury (AKI)

SeaStar Medical announces $4.4M registered direct offering priced at-the-market

2025-07-31T19:10:42.000Z - 1 year ago

SeaStar Medical announces $4.4M registered direct offering priced at-the-market

SeaStar Medical Announces $4.4 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

Jul 31, 2025, 3:01 PM EDT - 1 year ago

SeaStar Medical Announces $4.4 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

SeaStar Medical Reports Positive Results for QUELIMMUNE Therapy in Pediatric Acute Kidney Injury (AKI) from the First 20 SAVE Surveillance Registry Patients

Jul 22, 2025, 8:20 AM EDT - 1 year ago

SeaStar Medical Reports Positive Results for QUELIMMUNE Therapy in Pediatric Acute Kidney Injury (AKI) from the First 20 SAVE Surveillance Registry Patients

SeaStar Medical Grows Customer Base and Expands QUELIMMUNE Surveillance Registry

Jul 16, 2025, 8:45 AM EDT - 1 year ago

SeaStar Medical Grows Customer Base and Expands QUELIMMUNE Surveillance Registry

SeaStar Medical Announces $4 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

Jul 10, 2025, 3:29 PM EDT - 1 year ago

SeaStar Medical Announces $4 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

SeaStar Medical Expands QUELIMMUNE Adoption for Critically Ill Pediatric Patients with Acute Kidney Injury (AKI)

Jul 8, 2025, 8:05 AM EDT - 1 year ago

SeaStar Medical Expands QUELIMMUNE Adoption for Critically Ill Pediatric Patients with Acute Kidney Injury (AKI)

SeaStar Medical Announces Positive Nasdaq Listing Determination

Jul 2, 2025, 4:25 PM EDT - 1 year ago

SeaStar Medical Announces Positive Nasdaq Listing Determination

SeaStar Medical Reports Update on Nasdaq Listing Status

Jun 25, 2025, 8:05 AM EDT - 1 year ago

SeaStar Medical Reports Update on Nasdaq Listing Status

SeaStar Medical Announces Two Feature Stories on QUELIMMUNE Adoption and Patient Testimonial of Life-Saving Therapy

Jun 24, 2025, 9:05 AM EDT - 1 year ago

SeaStar Medical Announces Two Feature Stories on QUELIMMUNE Adoption and Patient Testimonial of Life-Saving Therapy

SeaStar Medical Announces Pricing of Up to $8 Million Public Offering

Jun 20, 2025, 12:10 PM EDT - 1 year ago

SeaStar Medical Announces Pricing of Up to $8 Million Public Offering

SeaStar Medical Holding Registration statement: Registration Filing

Jun 20, 2025, 8:00 AM EDT - 1 year ago

SeaStar Medical Holding Registration statement: Registration Filing

SeaStar Medical Holding Registration statement: Registration Filing

Jun 16, 2025, 8:00 AM EDT - 1 year ago

SeaStar Medical Holding Registration statement: Registration Filing

AREVA Institute and SeaStar Medical Announce DoD Award of Prestigious Military Grant to AREVA Institute to Evaluate SeaStar Medical's SCD Therapy to Advance Breakthrough Burn and Sepsis Research

Jun 11, 2025, 8:25 AM EDT - 1 year ago

AREVA Institute and SeaStar Medical Announce DoD Award of Prestigious Military Grant to AREVA Institute to Evaluate SeaStar Medical's SCD Therapy to Advance Breakthrough Burn and Sepsis Research

SeaStar Medical Announces CMS Coverage for Medicare and Medicaid Eligible Patients with Cardiorenal Syndrome Awaiting LVAD in Investigational Trial of SCD Therapy

May 28, 2025, 8:05 AM EDT - 1 year ago

SeaStar Medical Announces CMS Coverage for Medicare and Medicaid Eligible Patients with Cardiorenal Syndrome Awaiting LVAD in Investigational Trial of SCD Therapy

SeaStar Medical Holding Slides: Investor Presentation

May 20, 2025, 7:00 AM EDT - 1 year ago

SeaStar Medical Holding Slides: Investor Presentation

SeaStar Medical Holding Registration statement: Registration Filing

May 19, 2025, 8:00 AM EDT - 1 year ago

SeaStar Medical Holding Registration statement: Registration Filing

SeaStar Medical Holding Earnings Call Transcript: Q1 2025

May 14, 2025, 4:30 PM EDT - 1 year ago

SeaStar Medical Holding Earnings Call Transcript: Q1 2025

SeaStar Medical Holding Quarterly report: Q1 2025

May 14, 2025, 4:30 PM EDT - 1 year ago

SeaStar Medical Holding Quarterly report: Q1 2025

SeaStar Medical Holding Earnings release: Q1 2025

May 14, 2025, 4:30 PM EDT - 1 year ago

SeaStar Medical Holding Earnings release: Q1 2025

SeaStar Medical Reports First Quarter 2025 Financial Results and Provides Business Updates

May 14, 2025, 4:05 PM EDT - 1 year ago

SeaStar Medical Reports First Quarter 2025 Financial Results and Provides Business Updates

SeaStar Medical Reaches Interim Enrollment Target for NEUTRALIZE-AKI Pivotal Trial of SCD Therapy for Adult Patients with Acute Kidney Injury

May 13, 2025, 8:05 AM EDT - 1 year ago

SeaStar Medical Reaches Interim Enrollment Target for NEUTRALIZE-AKI Pivotal Trial of SCD Therapy for Adult Patients with Acute Kidney Injury

SeaStar Medical to Report First Quarter Financial Results on May 14, 2025

May 7, 2025, 10:00 AM EDT - 1 year ago

SeaStar Medical to Report First Quarter Financial Results on May 14, 2025

SeaStar Medical Holding Proxy statement: Proxy Filing

May 6, 2025, 8:00 AM EDT - 1 year ago

SeaStar Medical Holding Proxy statement: Proxy Filing

SeaStar Medical Holding Proxy statement: Proxy Filing

May 6, 2025, 8:00 AM EDT - 1 year ago

SeaStar Medical Holding Proxy statement: Proxy Filing

SeaStar Medical Announces CEO Interview on Benzinga All Access to Occur Today at Approximately 10:50 am Eastern Time

Apr 30, 2025, 8:05 AM EDT - 1 year ago

SeaStar Medical Announces CEO Interview on Benzinga All Access to Occur Today at Approximately 10:50 am Eastern Time

SeaStar Medical Holding Proxy statement: Proxy Filing

Apr 25, 2025, 8:00 AM EDT - 1 year ago

SeaStar Medical Holding Proxy statement: Proxy Filing

SeaStar Medical Holding Registration statement: Registration Filing

Apr 22, 2025, 8:00 AM EDT - 1 year ago

SeaStar Medical Holding Registration statement: Registration Filing

FDA Grants SeaStar Medical Two New Breakthrough Device Designations for SCD Therapy to Treat Systemic Inflammatory Response in Adult and Pediatric Patients Undergoing Cardiac Surgery

Apr 8, 2025, 8:05 AM EDT - 1 year ago

FDA Grants SeaStar Medical Two New Breakthrough Device Designations for SCD Therapy to Treat Systemic Inflammatory Response in Adult and Pediatric Patients Undergoing Cardiac Surgery

SeaStar Medical Holding Earnings Call Transcript: Q4 2024

Mar 27, 2025, 4:30 PM EDT - 1 year ago

SeaStar Medical Holding Earnings Call Transcript: Q4 2024

SeaStar Medical Holding Annual report: Q4 2024

Mar 27, 2025, 4:30 PM EDT - 1 year ago

SeaStar Medical Holding Annual report: Q4 2024

SeaStar Medical Holding Earnings release: Q4 2024

Mar 27, 2025, 4:30 PM EDT - 1 year ago

SeaStar Medical Holding Earnings release: Q4 2024

SeaStar Medical Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Updates

Mar 27, 2025, 4:05 PM EDT - 1 year ago

SeaStar Medical Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Updates

SeaStar Medical to Report Fourth Quarter and Year-End 2024 Financial Results on March 27, 2025

Mar 24, 2025, 5:30 PM EDT - 1 year ago

SeaStar Medical to Report Fourth Quarter and Year-End 2024 Financial Results on March 27, 2025

NKF Honors SeaStar Medical, with 2025 Corporate Innovator Award

Mar 18, 2025, 8:45 AM EDT - 1 year ago

NKF Honors SeaStar Medical, with 2025 Corporate Innovator Award

frogtrainer
frogtrainer Sep. 13 at 3:48 AM
$ICU is something supposed to happen on Monday?
0 · Reply
Duoma
Duoma Sep. 12 at 9:17 PM
$ICU Monday big bomb
1 · Reply
ICUBullbear
ICUBullbear Sep. 12 at 1:08 PM
$ICU if these prices are a gift youd think the insiders would be loading up..just looks like are mostly taking dilution shares 🚩🚩🚩
0 · Reply
et1000
et1000 Sep. 11 at 11:00 PM
Ticker MLEC is the next nano float runner ! Every small float ticker has been running almost 500% recently Would not be surprised if they send MLEC up next. MLEC starting to make its move now! Only 573k shares outstanding! 💎 $QQQ $ALT $ICU $NVAX in
1 · Reply
techjerk
techjerk Sep. 11 at 10:38 PM
$ICU SeaStar Medical did not exist during the September 11, 2001 terrorist attacks. 2007 (Founding): SeaStar Medical Holding Corporation was officially founded, coming into existence roughly six years after the 9/11 attacks occurred. 2022 (Public Listing): The company went public via a SPAC merger and began trading on the Nasdaq under the ticker symbol ICU.
1 · Reply
techjerk
techjerk Sep. 11 at 10:04 PM
$ICU investers here like vampires .. suck those shares!? i
1 · Reply
techjerk
techjerk Sep. 11 at 9:36 PM
$ICU .. 5050 from the past has riled thee .. ha
0 · Reply
local42r
local42r Sep. 11 at 9:13 PM
$ICU looks like you answered your own question.
1 · Reply
BULLISH1975
BULLISH1975 Sep. 11 at 7:03 PM
$ICU i like when Eric says SCD is working in the real world- results in line with trials. We know SAVE data is good. We know FDA dropped SAVE requirement from 300 - 50!!!!!! We have many shots at goal. Ped market is 100 million top 50 hospitals apparently treat half patients- about 50 million revenue We already have about 40 % of the top hospitals- this should mean about 20 million revenue potential from current hospital clients!!!!!! tock tock small fry compared to Adult BUt we making progress- just SP needs to catch UP👍
0 · Reply
BULLISH1975
BULLISH1975 Sep. 11 at 6:57 PM
$ICU investers dont flip every day or week. volume today is traders selling in a friday and some were hoping ICU was getting new data today. i holdddd stronggggg
2 · Reply
BULLISH1975
BULLISH1975 Sep. 11 at 6:55 PM
$ICU i judt listened to presentation!!!! all positive! Eric is sounding more confident than ever!!!! tick tock! saving lives Cardiorenal trial sounds exciting- chsnging SCD every 6 hours versus 24 hours means much much more SCd’s which means more REVENUE per treatment!!!! lots of moving parts exciting times! i got patience.
0 · Reply
4by
4by Sep. 11 at 6:44 PM
$ICU Whatever! 🤬
0 · Reply
techjerk
techjerk Sep. 11 at 6:42 PM
$ICU a real mkt cap here
0 · Reply
Yayo5050
Yayo5050 Sep. 11 at 6:36 PM
$ICU all brokers are listening it at 2.97, this is not a real time quote.
0 · Reply
Yayo5050
Yayo5050 Sep. 11 at 6:35 PM
$ICU Just had a conference and obviously investors did not like what they heard.
2 · Reply
BULLISH1975
BULLISH1975 Sep. 11 at 6:28 PM
$ICU there are a few flippers who are trying to time the news and rerate! good luck! have a great weekend. 🩷
0 · Reply
local42r
local42r Sep. 11 at 4:58 PM
$ICU who ever wants out, now is the because I'm buying all I can get. Steady adding. You need to go now, there's better opportunity for you elsewhere.
1 · Reply
Jw242
Jw242 Sep. 11 at 3:19 PM
$ICU just like that. Support broken
1 · Reply
BottomUp00
BottomUp00 Sep. 11 at 2:06 PM
$ICU
0 · Reply
Bluesir
Bluesir Sep. 11 at 1:21 PM
$ICU we are quoting more then 3$, we are waiting FDA news any day now, we have sales data increasing consistently quarter by quarter . Can you explain why on hell you keep mentioning R/S, not even 1, but 2 or 3. Go short and stop with your false alarm! GL
2 · Reply
ICUBullbear
ICUBullbear Sep. 11 at 12:19 PM
$ICU HCW presentation was the same old info. waste of money yet again. Seastar needs a better speaker Eric isnt cutting it. no wonder we cant get any real investors. we are definety looking at a couple rounds of dilution before adult and one more after that….RS almost cetain at this pace.. just the way Eric and team want it. you all will vote to give them anything they want 🤣 they will get their shares back.
0 · Reply